NASDAQ:AEMD Aethlon Medical (AEMD) Stock Price, News & Analysis $0.40 0.00 (-0.28%) Closing price 04:00 PM EasternExtended Trading$0.39 -0.01 (-1.99%) As of 05:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Aethlon Medical Stock (NASDAQ:AEMD) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Aethlon Medical alerts:Sign Up Key Stats Today's Range$0.38▼$0.4050-Day Range$0.33▼$0.4352-Week Range$0.24▼$1.06Volume159,977 shsAverage Volume2.34 million shsMarket Capitalization$6.39 millionP/E RatioN/ADividend YieldN/APrice Target$7.00Consensus RatingBuy Company OverviewAethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation. The company was incorporated in 1999 and is based in San Diego, California.Read More… Aethlon Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks34th Percentile Overall ScoreAEMD MarketRank™: Aethlon Medical scored higher than 34% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingAethlon Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageAethlon Medical has only been the subject of 1 research reports in the past 90 days.Read more about Aethlon Medical's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Aethlon Medical are expected to grow in the coming year, from ($0.73) to ($0.49) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Aethlon Medical is -0.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Aethlon Medical is -0.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAethlon Medical has a P/B Ratio of 0.18. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Aethlon Medical's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.64% of the outstanding shares of Aethlon Medical have been sold short.Short Interest Ratio / Days to CoverAethlon Medical has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Aethlon Medical has recently increased by 82.00%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAethlon Medical does not currently pay a dividend.Dividend GrowthAethlon Medical does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.64% of the outstanding shares of Aethlon Medical have been sold short.Short Interest Ratio / Days to CoverAethlon Medical has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Aethlon Medical has recently increased by 82.00%, indicating that investor sentiment is decreasing significantly. News and Social Media0.0 / 5News SentimentN/A Search InterestOnly 1 people have searched for AEMD on MarketBeat in the last 30 days. This is a decrease of -80% compared to the previous 30 days.MarketBeat FollowsOnly 4 people have added Aethlon Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of -20% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Aethlon Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.10% of the stock of Aethlon Medical is held by insiders.Percentage Held by InstitutionsOnly 1.99% of the stock of Aethlon Medical is held by institutions.Read more about Aethlon Medical's insider trading history. Receive AEMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aethlon Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address AEMD Stock News HeadlinesAethlon Medical (NASDAQ:AEMD) Coverage Initiated by Analysts at StockNews.comMay 15, 2025 | americanbankingnews.comAethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Platelet-Derived Extracellular Vesicles from PlasmaMay 14, 2025 | prnewswire.comTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.May 23, 2025 | Porter & Company (Ad)Aethlon Medical Publishes Preclinical Data on the Hemopurifier® in Transplant Immunology JournalMarch 10, 2025 | prnewswire.comAethlon Medical (AEMD) Receives a Hold from Maxim GroupFebruary 14, 2025 | markets.businessinsider.comAEMD: Patient Enrollments in Oncology Trial Expected to Accelerate With 3rd Participating Site, Protocol AmendmentsFebruary 14, 2025 | finance.yahoo.comAEMD: Patient Enrollments in Oncology Trial Expected to Accelerate With 3rd Participating Site, Protocol AmendmentsFebruary 14, 2025 | finance.yahoo.comAethlon Medical, Inc. (NASDAQ:AEMD) Q3 2025 Earnings Call TranscriptFebruary 13, 2025 | msn.comSee More Headlines AEMD Stock Analysis - Frequently Asked Questions How have AEMD shares performed this year? Aethlon Medical's stock was trading at $0.86 at the start of the year. Since then, AEMD shares have decreased by 53.7% and is now trading at $0.3979. View the best growth stocks for 2025 here. How were Aethlon Medical's earnings last quarter? Aethlon Medical, Inc. (NASDAQ:AEMD) posted its quarterly earnings results on Wednesday, February, 12th. The medical equipment provider reported ($0.13) EPS for the quarter, beating the consensus estimate of ($0.22) by $0.09. Read the conference call transcript. When did Aethlon Medical's stock split? Aethlon Medical shares reverse split on the morning of Thursday, October 5th 2023. The 1-10 reverse split was announced on Wednesday, October 4th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, October 4th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. Who are Aethlon Medical's major shareholders? Top institutional shareholders of Aethlon Medical include Armistice Capital LLC (8.89%). View institutional ownership trends. How do I buy shares of Aethlon Medical? Shares of AEMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Aethlon Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Aethlon Medical investors own include Advanced Micro Devices (AMD), Nokia Oyj (NOK), NVIDIA (NVDA), Pfizer (PFE), Plug Power (PLUG), Vaxart (VXRT) and Organigram (OGI). Company Calendar Last Earnings2/12/2025Today5/23/2025Next Earnings (Estimated)6/26/2025Fiscal Year End3/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:AEMD CIK773910 Webwww.aethlonmedical.com Phone(858) 459-7800FaxN/AEmployees10Year FoundedN/APrice Target and Rating Average Stock Price Target$7.00 High Stock Price Target$7.00 Low Stock Price Target$7.00 Potential Upside/Downside+1,654.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($1.58) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-12,210,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-153.96% Return on Assets-109.13% Debt Debt-to-Equity RatioN/A Current Ratio2.80 Quick Ratio2.80 Sales & Book Value Annual Sales$570,000.00 Price / Sales11.24 Cash FlowN/A Price / Cash FlowN/A Book Value$2.19 per share Price / Book0.18Miscellaneous Outstanding Shares16,061,000Free Float14,298,000Market Cap$6.41 million OptionableNo Data Beta1.93 Social Links The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free Report This page (NASDAQ:AEMD) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aethlon Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aethlon Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.